Fingerprint
Dive into the research topics of 'Patients with FLT3-mutant AML needed to enroll on FLT3-targeted therapeutic clinical trials'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Patients with FLT3-mutant AML needed to enroll on FLT3-targeted therapeutic clinical trials
Taylor Bucy, John M. Zoscak, Motomi Mori, Uma Borate
Research output: Contribution to journal › Review article › peer-review
2
Scopus
citations